America Great Health
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AAGH research report →
Price Chart
About the company
Operating as a U. S. -based biotechnology company, America Great Health (AAGH) focuses on two primary areas: the research and development of protein and peptide small molecular drugs, and the manufacturing and sale of a diverse portfolio including AI cloud computing-driven diagnostic and medical devices, cell therapies, regenerative medicine, and supplements.
- CEO
- Mike Qingkun Wang
- IPO
- 2012
- Employees
- 5
- HQ
- Alhambra, CA, US
Get TickerSpark's AI analysis on AAGH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.35M
- P/E
- 3.00
- PEG
- 0.03
- P/S
- 17.47
- P/B
- -1.32
- EV/EBITDA
- 6.72
- Div Yield
- 0.00%
- Gross Margin
- 68.58%
- Op Margin
- -105.19%
- Net Margin
- 175.26%
- ROE
- -12.13%
- ROIC
- 21.76%
Latest fiscal year · YoY change
- Revenue
- $391.74K+32.9%
- Gross Profit
- $339.12K+99.8%
- Op Income
- $-382,935
- Net Income
- $-721,242+40.9%
- EPS
- $0.00+100.0%
- OCF Growth
- +45.9%
- FCF Growth
- +45.9%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 5.96
- RSI (14)
- 66
- Avg Volume
- 1.09M
No earnings-call transcripts are available for AAGH yet.
- Free Float
- 90.5%
- Shares Outstanding
- 21.15B
- Float Shares
- 19.15B
Our AAGH coverage
Recent articles, reports, and earnings notes.
No research on AAGH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AAGH report →